GSK2838232
Product Specifications
CAS Number
1443460-91-0
Target
HIV Protease
Related Pathways
Proteases/Proteasome|||Microbiology/Virology
Purity
0.9905
Bioactivity
GSK2838232, a novel human immunodeficiency virus (HIV) maturation inhibitor, inhibits HIV reverse transcriptase activity across a broad panel of HIV-1 isolates.
Smiles
[H][C@]12CC[C@]3([H])[C@@]4(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@]4([H])CC[C@@]3(C)[C@]1(C)CC[C@]1(CC(=O)C(C(C)C)=C21)[C@@H](O)CN(CCN(C)C)Cc1ccc(Cl)cc1
Molecular Formula
C48H73ClN2O6
Molecular Weight
809.56
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1019399-01 0.02 mg (E-Coli)
Recombinant Escherichia coli UDP-2,3-diacylglucosamine hydrolase (lpxH)
Ask
View Details MBS1019399-02 0.1 mg (E-Coli)
Recombinant Escherichia coli UDP-2,3-diacylglucosamine hydrolase (lpxH)
Ask
View Details 
MBS1019399-03 0.02 mg (Yeast)
Recombinant Escherichia coli UDP-2,3-diacylglucosamine hydrolase (lpxH)
Ask
View Details MBS1019399-04 0.1 mg (Yeast)
Recombinant Escherichia coli UDP-2,3-diacylglucosamine hydrolase (lpxH)
Ask
View Details MBS1019399-05 0.02 mg (Baculovirus)
Recombinant Escherichia coli UDP-2,3-diacylglucosamine hydrolase (lpxH)
Ask
View Details 
MBS1019399-06 0.02 mg (Mammalian-Cell)
Recombinant Escherichia coli UDP-2,3-diacylglucosamine hydrolase (lpxH)
Ask
View Details